Targeting galectin-3 for treatment of nash mediated fibrosis
Ended Project Grant Awarded Last action
- Award ID
- R43DK120130
- Recipient
-
Glycomantra Inc. UEI GJJRLDPAL8M9
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $298,490
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $298,490 |
Quick answers
Who received award R43DK120130?
R43DK120130 was awarded to Glycomantra Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 18, 2018.
How much is award R43DK120130 worth?
$298,490 has been obligated on R43DK120130.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award